Ara
Toplam kayıt 5, listelenen: 1-5
Management of Hepatocellular Carcinoma: Prevention, Surveillance, Diagnosis, and Staging
(2017)
More than 600 000 people die from hepatocellular carcinoma each year. Worldwide, research on the disease needs to be intensified in both the medical and pharmaceutical fields, with a focus on providing help to geographic ...
Prognostic Factors and Staging Systems in Hepatocellular Carcinoma
(2017)
There are a number of factors that should be taken into consideration when predicting the outcomes and prognosis of hepatocellular carcinoma. Four of the most important factors in determining survival are the severity of ...
Liver Transplant for Hepatocellular Carcinoma: Pathologic Point Of View
(2017)
Primary liver cancer is the fifth most common cancer overall and the second most common cause of cancer mortality worldwide. Hepatocellular carcinoma accounts for up to 90% of all primary hepatic malignancies and represents ...
Hepatitis B- and Hepatitis D-Virus Related Liver Transplant: Single-Center Data
(2015)
Objectives: Hepatitis B and D virus coinfection or superinfection lead to chronic liver disease and have poor treatment results and poor prognosis. After transplant, these patients have difficult problems. We aimed to ...
Local Ablation for Hepatocellular Carcinoma
(2014)
Surgical options for hepatocellular carcinoma must be considered first; if not, image-guided tumor ablation is recommended. The Barcelona Clinic Liver Cancer classification system is commonly used for patients with ...